ライフサイエンスコーパス: absorptiometry

1 a body fat assessment via dual-energy x-ray absorptiometry.

2 ys and body composition by dual-energy X-ray absorptiometry.

3 ent of tHcy and whole-body dual-energy X-ray absorptiometry.

4 ean mass) were measured by dual-energy X-ray absorptiometry.

5 mposition were assessed by dual-energy X-ray absorptiometry.

6 g was assessed at birth by dual-energy X-ray absorptiometry.

7 e child were assessed with dual-energy X-ray absorptiometry.

8 at 3 WHI clinics by using dual-energy X-ray absorptiometry.

9 dy fat (LBF) was imaged by dual-energy x-ray absorptiometry.

10 -free mass and fat mass by dual-energy X-ray absorptiometry.

11 osition was measured using dual-energy x-ray absorptiometry.

12 ine (LS), as determined by dual-energy X-ray absorptiometry.

13 age fat (TBPF) measured by dual-energy X-ray absorptiometry.

14 ty that is not provided by dual-energy x-ray absorptiometry.

15 tion was assessed by using dual-energy X-ray absorptiometry.

16 ubjects underwent standard dual-energy x-ray absorptiometry.

17 rs using anthropometry and dual-energy X-ray absorptiometry.

18 eoporosis, measured by the dual-energy X-ray absorptiometry.

19 from baseline, assessed by dual-energy x-ray absorptiometry.

20 tion was measured by using dual-energy X-ray absorptiometry.

21 bar spine and total hip by dual-energy X-ray absorptiometry.

22 ty was determined by using dual-energy x-ray absorptiometry.

23 etermined using whole-body dual-energy X-ray absorptiometry.

24 -L4) was measured by using dual-energy X-ray absorptiometry.

25 free mass were measured by dual-energy X-ray absorptiometry.

26 body fat (%BF) measured by dual energy X-ray absorptiometry.

27 , and muscle mass by using dual-energy X-ray absorptiometry.

28 measurements obtained from dual-energy x-ray absorptiometry.

29 sity (BMD) was assessed by dual-energy x-ray absorptiometry.

30 and waist circumference on dual-energy x-ray absorptiometry.

31 by a whole-body scan using dual-energy X-ray absorptiometry.

32 percentage was measured by dual-energy X-ray absorptiometry.

33 BMD were measured by using dual-energy X-ray absorptiometry.

34 l neck and/or lumbar spine) using dual x-ray absorptiometry.

35 ass (FFM) were measured by dual-energy X-ray absorptiometry.

36 BMD was measured by using dual-energy X-ray absorptiometry.

37 ng Index (HEI) values, and dual-energy X-ray absorptiometry.

38 FFM were measured by using dual-energy X-ray absorptiometry.

39 ody composition was quantified by dual x-ray absorptiometry.

40 tion was measured by using dual-energy X-ray absorptiometry.

41 n on BMD at the hip, using dual-energy X-ray absorptiometry.

42 seline and 3 and 6 mo with dual-energy X-ray absorptiometry.

43 MD Z score was measured by dual-energy X-ray absorptiometry.

44 , and body composition via dual-energy x-ray absorptiometry.

45 , typically assessed using dual-energy X-ray absorptiometry.

46 d fat-free mass index with dual-energy X-ray absorptiometry.

47 density, was determined by dual-energy X-ray absorptiometry.

48 n mass were measured using dual-energy-x-ray absorptiometry.

49 (FFMI) were measured with dual-energy X-ray absorptiometry.

50 e measured with the use of dual-energy X-ray absorptiometry.

51 ass were measured by using dual-energy X-ray absorptiometry.

52 n changes were measured by dual-energy X-ray absorptiometry.

53 d at birth with the use of dual-energy X-ray absorptiometry.

54 BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and other la

55 , and appendicular mass by dual-energy X-ray absorptiometry; activity-related energy expenditure (ARE

56 Body composition (dual-energy X-ray absorptiometry), ad libitum energy intake (EI; buffet),

57 omposition was measured by dual-energy X-ray absorptiometry and abdominal computed tomographic scans.

58 icipants were evaluated by dual-energy x-ray absorptiometry and abdominal magnetic resonance imaging.

59 Dual-energy x-ray absorptiometry and anthropometric data were used to dete

60 s, and body composition by dual-energy X-ray absorptiometry and BP at 9 years, were analysed (n = 657

61 agnetic resonance imaging, dual-energy X-ray absorptiometry and carotid ultrasound.

62 late to regional fat gain (dual energy X-ray absorptiometry and computed tomography) and baseline pre

63 osition (measured by using dual-energy X-ray absorptiometry and computed tomography), insulin sensiti

64 Body fat was measured with dual energy X-ray absorptiometry and computed tomography.

65 s with fat measurements by dual-energy x-ray absorptiometry and computed tomography.

66 tribution were measured by dual-energy x-ray absorptiometry and computed tomography.

67 ssed with a combination of dual-energy X-ray absorptiometry and computed tomography.

68 Lean mass was estimated by dual X-ray absorptiometry and examined as leg lean mass (LLM), ALM,

69 sment (VFA) performed with dual-energy x-ray absorptiometry and if VFs identified by CNNs confer a si

70 data, including clinical, dual-energy X-ray absorptiometry and laboratory data, are also reported.

71 actures have lower aBMD by dual-energy x-ray absorptiometry and lower vBMD, thinner cortices, and tra

72 asured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); cir

73 at mass, fat distribution (dual-energy X-ray absorptiometry and magnetic resonance imaging), and meta

74 ) body fat distribution by dual energy x-ray absorptiometry and magnetic resonance imaging.

75 fat ratio with the use of dual-energy X-ray absorptiometry and measured the preperitoneal abdominal

76 ity was analyzed using peripheral dual x-ray absorptiometry and micro-computed tomography.

77 llas Heart Study underwent dual energy x-ray absorptiometry and MRI assessment of fat distribution, L

78 nt body fat (BF) was assessed via dual X-ray absorptiometry and PA was determined via a multi-sensor

79 as evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness.

80 infant body composition by dual-energy X-ray absorptiometry and used untargeted liquid chromatography

81 bed rest, lean body mass (dual-energy X-ray absorptiometry) and quadriceps cross-sectional area (CSA

82 graphy), body composition (dual-energy x-ray absorptiometry), and blood parameters.

83 e test), body composition (dual-energy X-ray absorptiometry), and ectopic fat (MRI) were assessed pre

84 n force, body composition (dual-energy X-ray absorptiometry), and muscle cross-sectional area (magnet

85 ment (echocardiography and dual-energy x-ray absorptiometry); and histology and molecular evaluation.

86 us-glucose-tolerance test, dual-energy X-ray absorptiometry, and computed tomography, respectively.

87 MD) were assessed by using dual-energy X-ray absorptiometry, and fasting blood was collected for the

88 position was quantified by dual-energy x-ray absorptiometry, and insulin resistance was assessed by g

89 dy fat was determined with dual-energy X-ray absorptiometry, and intraabdominal adipose tissue (IAAT)

90 ndex and fat mass index by dual-energy X-ray absorptiometry, and organ fat including subcutaneous fat

91 total fat mass index from dual-energy x-ray absorptiometry, and overweight or obesity, defined as a

92 water, body composition by dual-energy X-ray absorptiometry, and physical activity by accelerometry.

93 :gynoid fat ratio by using dual-energy X-ray absorptiometry, and preperitoneal abdominal fat by using

94 omposition with the use of dual-energy X-ray absorptiometry, and questionnaire-derived perceptions of

95 eight, body composition by dual-energy X-ray absorptiometry, and resting energy expenditure by indire

96 urine calcium measurement, dual-energy x-ray absorptiometry, and supplementation for vitamin D defici

97 by physical examinations, dual-energy x-ray absorptiometry, and ultrasound, respectively.

98 O2]), percent body fat via dual-energy x-ray absorptiometry, and visceral fat via magnetic resonance,

99 mass (FM) were assessed by dual-energy X-ray absorptiometry annually over a mean (+/-SD) of 4.9 +/- 1

100 amp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visc

101 Dual x-ray absorptiometry-assessed body composition (including lean

102 e aged 4 and 6 y were BMI, dual-energy X-ray absorptiometry-assessed fat mass, overweight, or obesity

103 nd at 4 and 6 y of age for dual-energy X-ray absorptiometry assessment of lean and fat mass.

104 In a subgroup (n = 766), dual-energy X-ray absorptiometry assessment of total abdominal fat was per

105 k) were evaluated by using dual-energy X-ray absorptiometry at 5 and 20 wk postpartum.

106 who had been scanned with dual-energy X-ray absorptiometry at 52 wk of lactation (L52; n = 79) were

107 body composition was assessed by dual X-ray absorptiometry at age 2 weeks.

108 he offspring had undergone dual-energy x-ray absorptiometry at age 9-10 years.

109 mineral density was measured with dual x-ray absorptiometry at baseline and again an average of 4.6 y

110 MD) were assessed by using dual-energy X-ray absorptiometry at baseline and at 2 annual follow-up vis

111 was measured by total-body dual-energy x-ray absorptiometry at study baseline and at 12, 24, and 36 m

112 s measured with the use of dual-energy X-ray absorptiometry at Tanner stage 4.

113 nthropometric measures and dual-energy X-ray absorptiometry at the baseline visit.

114 Patients underwent dual x-ray absorptiometry at the hip and spine and hand radiography

115 bone area were assessed by dual-energy X-ray absorptiometry at the median age of 6 y.

116 al body bone mass by using dual-energy X-ray absorptiometry at the median age of 6.0 y.

117 (BMC) Z-scores measured by dual energy X-ray absorptiometry at the one-third distal radius, in a coho

118 mineral density (aBMD) by dual-energy x-ray absorptiometry at the spine, hip, and radius, and we mea

119 m baseline in areal BMD by dual-energy x-ray absorptiometry at the total hip through month 12 (mean o

120 on than that achieved with dual-energy x-ray absorptiometry-based BMD.

121 tion of anthropometric and dual-energy X-ray absorptiometry-based measures of adiposity with IS [QUan

122 omposition was measured by dual-energy x-ray absorptiometry biweekly, resting energy expenditure was

123 density (BMD) measured by dual-energy X-ray absorptiometry, blood samples, diet, physical activity,

124 omposition with the use of dual-energy X-ray absorptiometry, blood volume with the use of a carbon mo

125 luated in association with dual-energy x-ray absorptiometry body composition measures among 15,028 ad

126 Using yearly dual-energy x-ray absorptiometry, body composition was assessed in the Hea

127 knesses, and waist girth), dual-energy X-ray absorptiometry, body density, bioelectrical impedance, a

128 ity (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructural proper

129 ition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blo

130 Genome Project focusing on Dual-Energy X-Ray Absorptiometry data for the analysis of mouse knockout d

131 Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES w

132 basis of NHANES 1999-2004 dual-energy X-ray absorptiometry data, provide a reference in the US adult

133 Measures of dual-energy X-ray absorptiometry-derived fat mass included the limb-to-tru

134 England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes </=11 kg/m(2) in

135 England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes of >/=13 kg/m(2)

136 l assessment, body weight, dual-energy X-ray absorptiometry (DEXA) for body composition, echocardiogr

137 as assessed using repeated dual-energy x-ray absorptiometry (DEXA) scans.

138 ciaries with HIV underwent dual energy x-ray absorptiometry (DEXA) screening in 2001-2.

139 Dual X-ray absorptiometry (DEXA) was used to determine bone mineral

140 gnetic resonance imaging (MRI) and dual Xray absorptiometry (DEXA).

141 sonance imaging (MRI), and dual-energy x-ray absorptiometry (DEXA).

142 ce underwent live imaging (dual energy x-ray absorptiometry [DEXA] scanning, two-dimensional echocard

143 Lumbar spine dual X-ray absorptiometry does not consistently distinguish childre

144 ed the newly described method of dual photon absorptiometry (DPA) to demonstrate that osteoporotic wo

145 easures compare with FM by dual-energy X-ray absorptiometry (DXA) 2 wk postpartum.

146 Dual-energy X-ray absorptiometry (DXA) analysis was performed in children

147 measures obtained by using dual-energy X-ray absorptiometry (DXA) and anthropometric measures.

148 otal body protein by using dual-energy X-ray absorptiometry (DXA) and bioimpedance analysis (BIA).

149 subsequent development of dual-energy x-ray absorptiometry (DXA) and quantitative computed tomograph

150 and bone mineral density (BMD) by Dual X-Ray Absorptiometry (DXA) and repeated after 12 weeks of regu

151 ), waist circumference and Dual-energy X-ray absorptiometry (DXA) assessed fat mass), and logistic re

152 asure with the use of only dual-energy X-ray absorptiometry (DXA) attenuation values for use in Lohma

153 ort members with age 15 yr dual-energy x-ray absorptiometry (DXA) bone outcomes (whole body, lumbar s

154 rs old in 1976 underwent a dual-energy X-ray absorptiometry (DXA) bone scan.

155 Dual energy X-ray absorptiometry (DXA) can be used to determine abdominal

156 Dual-energy x-ray absorptiometry (DXA) can provide accurate measurements o

157 dependent association with dual-energy X-ray absorptiometry (DXA) derived body-fat distribution trait

158 Dual-energy X-ray absorptiometry (DXA) derived measures of lean mass demon

159 10 years and had undergone dual-energy x-ray absorptiometry (DXA) during the previous 12 months.

160 ore, skinfold thicknesses, dual-energy X-ray absorptiometry (DXA) fat mass, DXA lean mass, height z s

161 Dual-energy x-ray absorptiometry (DXA) for visceral adipose tissue (VAT) a

162 5 (mean 8.3 years apart) and hip dual x-ray absorptiometry (DXA) had been performed (2 years after b

163 mechanical CT analysis and dual-energy x-ray absorptiometry (DXA) in 136 women (age range, 43-92 year

164 mineral density (aBMD) by dual-energy X-ray absorptiometry (DXA) in midchildhood.

165 es for the clinical use of dual-energy X-ray absorptiometry (DXA) in the diagnosis and treatment of o

166 nsity (BMD) measurement by dual-energy x-ray absorptiometry (DXA) is an internationally accepted stan

167 y (CT) in combination with dual-energy x-ray absorptiometry (DXA) is cost-effective as a screening to

168 density (aBMD) assessed by dual-energy x-ray absorptiometry (DXA) is the clinical standard for determ

169 7 years) using anthropometric and dual X-ray absorptiometry (DXA) measurements.

170 Recently, dual-energy X-ray absorptiometry (DXA) modeling of organ-tissue mass combi

171 e food intake measures and dual-energy X-ray absorptiometry (DXA) scan for body composition will be c

172 rtebrae were imaged with a dual-energy x-ray absorptiometry (DXA) scanner, a clinical energy-integrat

173 )R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabecular and co

174 (DLW) along with multiple dual-energy X-ray absorptiometry (DXA) scans to measure changes in body en

175 Dual-energy x-ray absorptiometry (DXA) scans were performed before startin

176 ty at week 48, assessed by dual energy x-ray absorptiometry (DXA) scans.

177 hat is easily derived from dual-energy X-ray absorptiometry (DXA) scans.

178 Dual-energy X-ray absorptiometry (DXA) was used for an assessment of bone

179 height and breast composition by dual X-ray absorptiometry (DXA) were measured in daughters at Tanne

180 n changes were measured by dual-energy X-ray absorptiometry (DXA) which were combined with energy int

181 minal multidetector CT and dual-energy x-ray absorptiometry (DXA) within 6 months of each other betwe

182 within 2 weeks of birth by dual-energy x-ray absorptiometry (DXA), analysed in all randomly assigned

183 e mineral density (BMD) by dual-energy x-ray absorptiometry (DXA), and BMD by quantitative computed t

184 ts aged 8 to 20 years with dual-energy x-ray absorptiometry (DXA), anthropometric, demographic, and p

185 Participants had dual-energy x-ray absorptiometry (DXA), entered a clinical BMD registry, a

186 tence, and remodeling with dual energy x-ray absorptiometry (DXA), high-resolution peripheral quantit

187 We used dual-energy x-ray absorptiometry (DXA), high-resolution peripheral quantit

188 sment Tool (FRAX), without dual-energy X-ray absorptiometry (DXA), in all HIV-infected men aged 40-49

189 f Pb on bone quality using dual-energy X-ray absorptiometry (DXA), micro-computed tomography, Raman s

190 y composition, measured by dual-energy x-ray absorptiometry (DXA), to increased serum alanine aminotr

191 y fat and muscle depots on dual-energy X-ray absorptiometry (DXA), whole-body MRI, and cardiac MRI.

192 ernate measure of obesity, dual-energy X-ray absorptiometry (DXA)-derived visceral-fat-volume measure

193 dy composition was measured using dual x-ray absorptiometry (DXA).

194 Fat mass was measured with dual-energy x-ray absorptiometry (DXA).

195 mposition were measured by dual-energy X-ray absorptiometry (DXA).

196 l BMD were determined with dual-energy x-ray absorptiometry (DXA).

197 L4) were measured by using dual-energy X-ray absorptiometry (DXA).

198 ge 20 y through the use of dual-energy X-ray absorptiometry (DXA).

199 els; (3) total body fat by dual energy x-ray absorptiometry (DXA); (4) liver and muscle insulin sensi

200 ergy stores [measured with dual-energy X-ray absorptiometry (DXA)] and energy expenditure [measured w

201 offspring fatness (BMI and dual-energy X-ray absorptiometry [DXA] determined fat mass index [FMI]) in

202 ging methods (radiography, dual-energy x-ray absorptiometry [DXA], and quantitative computed tomograp

203 alternative tests (central dual-energy x-ray absorptiometry [DXA], calcaneal quantitative ultrasonogr

204 at percentage (measured by dual energy X-ray absorptiometry, DXA) among girls (percentage of estimate

205 Leg lean mass (via dual-energy X-ray absorptiometry; DXA) and strength were determined.

206 equal to 2 posttransplant dual energy X-ray absorptiometry examinations.

207 imetry), body composition (dual-energy X-ray absorptiometry), fasting appetite ratings (visual analog

208 of dynamic knee loads as well as dual x-ray absorptiometry for determination of bone mineral density

209 and bone mass measured by dual-energy X-ray absorptiometry for each study year.

210 phy, and less precisely by dual-energy X-ray absorptiometry for osteodensitometry.

211 mposition data measured by dual-energy X-ray absorptiometry from NHANES.

212 e mass were measured using dual energy x-ray absorptiometry; grip strength and information on lifesty

213 Body composition (by absorptiometry), HMW adiponectin, and IGF-I were assesse

214 an TBS was calculated from dual-energy X-ray absorptiometry images at the L1 to L4 lumbar spine using

215 an (SD) whole-body BMD z score by dual x-ray absorptiometry improved by 0.25 (0.78) in the interventi

216 etal muscle mass using whole-body dual X-ray absorptiometry in 142 adult lung transplant candidates.

217 19 y was measured by using dual-energy X-ray absorptiometry in 1999-2004 as part of a health examinat

218 tion was measured by using dual-energy X-ray absorptiometry in 294 adult women at risk of weight gain

219 tion was measured by using dual-energy X-ray absorptiometry in 50 female, adult patients with AN befo

220 and FM were assessed using dual-energy x-ray absorptiometry in 78 CD subjects at diagnosis, 6, 12, an

221 dy composition measured by dual-energy X-ray absorptiometry in 984 Hispanic children and adolescents

222 composition as measured by dual-energy X-ray absorptiometry in a large sample of twins from the Twins

223 BF% was measured by dual-energy x-ray absorptiometry in a population-based cross-sectional stu

224 and spine were detected by dual-energy x-ray absorptiometry in both groups.

225 and adiposity measured by dual-energy X-ray absorptiometry in US children.

226 s and whole-body fat mass (dual-energy X-ray absorptiometry) increased over 12 weeks in Control by 1.

227 feeding through the use of dual-energy X-ray absorptiometry, indirect calorimetry, and ELISA.

228 wer radiation emissions by dual-energy X-ray absorptiometry instruments now permit the safe measureme

229 essments of body composition (via dual X-ray absorptiometry), insulin sensitivity (via hyperinsulinem

230 Dual x-ray absorptiometry is currently the state-of-the-art techniq

231 ures, but correlation with dual-energy x-ray absorptiometry is low.

232 density (BMD) measured by dual-energy x-ray absorptiometry is used to assess bone health in kidney t

233 n mass were collected from Dual-energy X-ray absorptiometry machine.

234 is of the relation between dual-energy x-ray absorptiometry-measured fat mass and BMI (in kg/m(2)) st

235 quations and compared with dual-energy x-ray absorptiometry measurements in a subgroup.

236 neonatal anthropometry and dual-energy X-ray absorptiometry measurements of neonatal lean mass in 102

237 f 8.2 years (766 follow-up dual energy X-ray absorptiometry measurements).

238 nsulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat dist

239 remodeling were evaluated by dual beam X-ray absorptiometry, micro-computed tomography, and histomorp

240 implant sites were assessed with dual x-ray absorptiometry, microcomputed tomography, and histology.

241 of body fat (adiposity) by dual-energy x-ray absorptiometry, moderate-to-vigorous physical activity u

242 ined body composition with dual-energy X-ray absorptiometry, muscle strength with a handgrip dynamome

243 ormed for patients evaluated with dual x-ray absorptiometry (n = 2106).

244 and body fat distribution (dual-energy x-ray absorptiometry) of rilpivirine (RPV) and EFV plus 2 nucl

245 n = 28,330) measured using dual energy X-ray absorptiometry or bioelectrical impedance analysis, adju

246 anning modalities, such as dual-energy X-ray absorptiometry or quantitative CT, have been developed a

247 come was lean body mass by dual-energy x-ray absorptiometry over the 12 week treatment period in elig

248 position was measured annually by dual X-ray absorptiometry, physical activity by accelerometry, and

249 Dual-energy x-ray absorptiometry predicts fractures similarly for men and

250 hapter, with subsections on methods based on absorptiometry, reflectometry, luminescence, refractive

251 asting blood samples and a dual-energy X-ray absorptiometry scan (subset of 650) from which metabolic

252 th the use of a total body dual-energy X-ray absorptiometry scan at 20 y of age.

253 a, referred for a baseline dual-energy x-ray absorptiometry scan from January 1, 1996, to March 28, 2

254 thropometric measurements, dual-energy X-ray absorptiometry scan, as well as dietary and activity ass

255 By dual-energy X-ray absorptiometry scan, body composition was unaltered at 3

256 ycemic clamp, VO2max test, dual-energy X-ray absorptiometry scan, underwater weighing, and muscle bio

257 Whole-body dual-energy X-ray absorptiometry scanning revealed that bone-mass accrual

258 Dual-energy X-ray absorptiometry scanning was done at baseline and week 48

259 mposition assessment using dual energy x-ray absorptiometry scanning with energy expenditure measured

260 try (hearing loss, 22.6%), dual-energy x-ray absorptiometry scans (low bone mineral density [BMD], 23

261 eatment with 2 consecutive dual-energy x-ray absorptiometry scans (mean interval, 4.5 years).

262 total and subregions) measured by dual x-ray absorptiometry scans and complete information on covaria

263 measures were derived from dual-energy X-ray absorptiometry scans at a mean age of 9.9 y.

264 d a subset with whole-body dual-energy X-ray absorptiometry scans at baseline and during follow-up.

265 tween the first and second dual-energy x-ray absorptiometry scans categorized as stable, detectable d

266 and 1998 who had received dual-energy x-ray absorptiometry scans for estimation of total body fat (T

267 y specific software on the dual-energy x-ray absorptiometry scans of lumbar spine in 39 KTR and 77 co

268 g of the trial, and serial dual-energy x-ray absorptiometry scans of the lumbar spine were performed.

269 bdominal CT scans and whole-body dual-energy absorptiometry scans over a 96-week period in human immu

270 in which serial whole-body dual-energy X-ray absorptiometry scans were performed.

271 al body fat, measured from dual energy x-ray absorptiometry scans, was the primary outcome.

272 Dual energy X-ray absorptiometry studies revealed increased central fat ma

273 percentage of fat by using dual-energy X-ray absorptiometry, symptoms of depression and anxiety, and

274 gility fractures at better dual-energy x-ray absorptiometry T-scores than those with postmenopausal o

275 For the subset with dual x-ray absorptiometry T-scores, 2-year AUC was 0.74 for bone at

276 There are limitations of dual-energy x-ray absorptiometry technology in this population, including

277 d the aBMD with the use of dual-energy X-ray absorptiometry, the distal radius and tibia bone microst

278 ' anthropometrics and used dual-energy X-ray absorptiometry to assess body composition at 1, 4, and 7

279 ears]) were evaluated with dual-energy x-ray absorptiometry to determine lumbar spine BMD and total-b

280 al muscle phenotypes using dual energy x-ray absorptiometry, ultrasound and isokinetic dynamometry.

281 estimated with the use of dual-energy X-ray absorptiometry, underwater weighing (UWW), and TBW.

282 lean body mass measured by dual-energy x-ray absorptiometry was analyzed as z scores.

283 Dual-energy X-ray absorptiometry was performed at baseline and 24-week int

284 dy composition assessed by Dual Energy X-ray Absorptiometry was performed.

285 ge in body fat measured by dual-energy X-ray absorptiometry was smaller (P = 0.001) in the CLA group

286 Dual-energy X-ray absorptiometry was used to assess body composition with

287 Dual-energy X-ray absorptiometry was used to assess body composition.

288 Dual-energy X-ray absorptiometry was used to measure total bone mineral co

289 BMD, measured using dual-energy x-ray absorptiometry, was assessed at the lumbar spine, femora

290 Using dual-energy X-ray absorptiometry, we compared lumbar spine, total hip, and

291 Cycle ergometry and dual-energy X-ray absorptiometry were obtained in 50 TX and 70 controls, a

292 Laboratory analysis and dual energy X-ray absorptiometry were performed at baseline and every 12 m

293 cords, accelerometers, and dual-energy X-ray absorptiometry were used to assess diet, activity, and b

294 etic resonance imaging and dual-energy x ray absorptiometry) were assessed using multivariable linear

295 mp), and body composition (dual-energy X-ray absorptiometry) were examined.

296 mposition (BC, measured by dual-energy X-ray absorptiometry) were measured at 3M-PP and 9M-PP (n = 49

297 nce, and body composition (dual-energy X-ray absorptiometry) were measured before and after 5 and 10

298 body-composition data (by dual-energy X-ray absorptiometry) were used.

299 fat-free mass, measured by dual-energy X-ray absorptiometry, were converted to calorie equivalents an

300 fat was measured by using dual-energy X-ray absorptiometry, whereas abdominal VAT and SAT cross-sect